Evidence map›Paper›PMID 39902106›Full record

ArticleRSC advances2025

Porphyrin-based porous organic polymer for the NIR-enhanced delivery of bupivacaine towards pain management in bacterial infection therapy.

Lichao Chu, Chunyu Dong, Shuai Wang, Xin Ding, Jingsong Yuan, Peilei Chen, Yanhua Luo, Lingzhi Yu

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lichao ChuJinan Central Hospital, Shandong University Jinan Shandong PR China pain-relief@163.com.
Chunyu DongDepartment of Neurointervention, Weihai Central Hospital Affiliated to Qingdao University Weihai Shandong PR China.
Shuai WangWeifang People's Hospital, Shandong Second Medical University Weifang 261035 Shandong PR China 55358645@qq.com.
Xin DingWeifang People's Hospital, Shandong Second Medical University Weifang 261035 Shandong PR China 55358645@qq.com.
Jingsong YuanWeifang People's Hospital, Shandong Second Medical University Weifang 261035 Shandong PR China 55358645@qq.com.
Peilei ChenWeifang People's Hospital, Shandong Second Medical University Weifang 261035 Shandong PR China 55358645@qq.com.
Yanhua LuoWeifang People's Hospital, Shandong Second Medical University Weifang 261035 Shandong PR China 55358645@qq.com.ORCID https://orcid.org/0009-0009-7467-1572
Lingzhi YuJinan Central Hospital, Shandong University Jinan Shandong PR China pain-relief@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic-free strategies have gained widespread attention in combating bacterial infection-related wound therapy. Phototherapy is a precise treatment method that stands out from other therapeutic strategies. However, under the stimulus of local heat, patients might unconsciously touch the dressing at the infection sites, causing the dressing to fall off, thereby greatly diminishing the treatment effect. Therefore, pain management is quite essential in phototherapy. Herein, a porphyrin-based porous organic polymer (POP) with excellent photothermal capacities, denoted as P-POP, was developed as a carrier for the seamless integration of bupivacaine hydrochloride (BU), with both antibacterial and analgesic effects, to obtain a novel composite (P-POP-BU). The repetitive porphyrin units endowed excellent thermo-responsive properties to P-POP-BU, realizing the accelerated drug release following the local temperature increase triggered by laser illumination. P-POP-BU could realize the photo-enhanced BU release, enabling pain management during PTT. The antibacterial experiment demonstrated that the composite presented a synergistic and high-efficiency capacity to eradicate bacteria at the infection sites and significantly accelerate the repairing of wounds under laser irradiation. Notably, this special composite exhibited excellent biocompatibility with minimal side effects, making it a promising therapeutic platform for the light-triggered treatment of bacterial infections.

Identifiers

PMID39902106
PMCPMC11788716

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.